⌘K

Login Start Free

Home/Filings/4/0000059478-24-000023

4//SEC Filing

Ricks David A 4

Accession 0000059478-24-000023

CIK 0000059478other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:28 PM ET

Size

10.4 KB

Accession

0000059478-24-000023

Insider Transaction Report

Form 4

Period: 2024-02-01

ELI LILLY & CoLLY

SVP and Pres, Lilly Bio-Meds

Transactions

Exercise/Conversion
Common Stock
2024-02-01+29,611→ 455,054 total
Tax Payment
Common Stock
2024-02-01$645.61/sh−13,240$8,547,876→ 441,814 total
Exercise/Conversion
Restricted Stock Unit
2024-02-01−29,611→ 0 total
From: 2024-02-01Exp: 2024-02-01→ Common Stock (29,611 underlying)

Holdings

Common Stock
(indirect: By David A. Ricks SLAT)
67,700
Common Stock
(indirect: By David A. Ricks 2022 GRAT)
63,758
Common Stock
(indirect: By 401(k))
7,223

Footnotes (2)

[F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
[F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file

4
wk-form4_1706909271.xmlPrimary
FORM 4

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1

filerCIK 0001538604

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 4:28 PM ET
Size: 10.4 KB

View on SEC.gov